The Cooper Companies, Inc. (COO)
USD 92.39
(-2.22%)
USD 92.39
(-2.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 882.8 Million USD | -1.08% |
| 2022 | 908.6 Million USD | 7.78% |
| 2021 | 863.7 Million USD | 49.99% |
| 2020 | 622.9 Million USD | -34.47% |
| 2019 | 826.2 Million USD | 14.77% |
| 2018 | 689.7 Million USD | 18.13% |
| 2017 | 613.6 Million USD | 29.58% |
| 2016 | 520.1 Million USD | 34.23% |
| 2015 | 425 Million USD | -16.21% |
| 2014 | 442.7 Million USD | -8.73% |
| 2013 | 446.78 Million USD | 19.24% |
| 2012 | 398.43 Million USD | 45.32% |
| 2011 | 305.35 Million USD | 3.22% |
| 2010 | 244.89 Million USD | 21.44% |
| 2009 | 238.57 Million USD | -19.12% |
| 2008 | 206.27 Million USD | 38.95% |
| 2007 | 126.96 Million USD | -21.15% |
| 2006 | 168.23 Million USD | -3.5% |
| 2005 | 132.95 Million USD | 53.57% |
| 2004 | 130.66 Million USD | 23.78% |
| 2003 | 107.76 Million USD | 44.08% |
| 2002 | 78.33 Million USD | 13.35% |
| 2001 | 65.74 Million USD | 16.25% |
| 2000 | 55.6 Million USD | 18.3% |
| 1999 | 47.25 Million USD | 21.76% |
| 1998 | 38.2 Million USD | 26.97% |
| 1997 | 24.1 Million USD | 51.24% |
| 1996 | 20.1 Million USD | 37.67% |
| 1995 | 11.4 Million USD | 3020.0% |
| 1994 | -600 Thousand USD | 96.58% |
| 1993 | -18.7 Million USD | 52.9% |
| 1992 | -19.4 Million USD | 26.19% |
| 1991 | -29.2 Million USD | -145.38% |
| 1990 | -11.9 Million USD | -1222.22% |
| 1989 | -900 Thousand USD | -101.6% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 281.5 Million USD | 3.84% |
| 2024 Q2 | 260 Million USD | 4.03% |
| 2024 Q1 | 249.9 Million USD | 15.48% |
| 2023 Q4 | 179.2 Million USD | -6.81% |
| 2023 Q2 | 138.2 Million USD | -29.02% |
| 2023 Q3 | 192.3 Million USD | 39.15% |
| 2023 Q1 | 194.7 Million USD | 37.89% |
| 2023 FY | - USD | -1.08% |
| 2022 Q3 | 174.5 Million USD | -22.65% |
| 2022 Q2 | 225.6 Million USD | 32.08% |
| 2022 Q4 | 141.2 Million USD | -19.08% |
| 2022 FY | - USD | 7.78% |
| 2022 Q1 | 170.8 Million USD | 4.98% |
| 2021 Q1 | 180.6 Million USD | 34.18% |
| 2021 Q3 | 137.8 Million USD | -23.27% |
| 2021 Q4 | 162.7 Million USD | 18.07% |
| 2021 Q2 | 179.6 Million USD | -0.55% |
| 2021 FY | - USD | 49.99% |
| 2020 FY | - USD | -34.47% |
| 2020 Q1 | 143.9 Million USD | -19.25% |
| 2020 Q3 | 106.3 Million USD | 90.84% |
| 2020 Q4 | 134.6 Million USD | 26.62% |
| 2020 Q2 | 55.7 Million USD | -61.29% |
| 2019 Q4 | 178.2 Million USD | -1.49% |
| 2019 FY | - USD | 14.77% |
| 2019 Q1 | 148.6 Million USD | -13.45% |
| 2019 Q2 | 164.5 Million USD | 10.7% |
| 2019 Q3 | 180.9 Million USD | 9.97% |
| 2018 Q3 | 150.9 Million USD | -9.15% |
| 2018 Q2 | 166.1 Million USD | 28.56% |
| 2018 Q1 | 129.2 Million USD | 3.69% |
| 2018 FY | - USD | 18.13% |
| 2018 Q4 | 171.7 Million USD | 13.78% |
| 2017 Q3 | 133.2 Million USD | -0.52% |
| 2017 FY | - USD | 29.58% |
| 2017 Q4 | 124.6 Million USD | -6.46% |
| 2017 Q1 | 104.2 Million USD | 17.22% |
| 2017 Q2 | 133.9 Million USD | 28.5% |
| 2016 Q3 | 116.95 Million USD | 11.85% |
| 2016 FY | - USD | 34.23% |
| 2016 Q4 | 88.89 Million USD | -23.99% |
| 2016 Q1 | 72.2 Million USD | 33.08% |
| 2016 Q2 | 104.56 Million USD | 44.81% |
| 2015 Q3 | 61.78 Million USD | -26.45% |
| 2015 FY | - USD | -16.21% |
| 2015 Q4 | 54.26 Million USD | -12.18% |
| 2015 Q2 | 84 Million USD | -1.18% |
| 2015 Q1 | 85 Million USD | 63.14% |
| 2014 Q2 | 96.85 Million USD | 9.29% |
| 2014 Q4 | 52.1 Million USD | -49.24% |
| 2014 Q1 | 88.61 Million USD | -3.4% |
| 2014 FY | - USD | -8.73% |
| 2014 Q3 | 102.63 Million USD | 5.97% |
| 2013 Q3 | 101.18 Million USD | 13.81% |
| 2013 Q4 | 91.74 Million USD | -9.33% |
| 2013 Q1 | 90.91 Million USD | -1.89% |
| 2013 Q2 | 88.9 Million USD | -2.21% |
| 2013 FY | - USD | 19.24% |
| 2012 Q1 | 67.28 Million USD | -46.58% |
| 2012 FY | - USD | 45.32% |
| 2012 Q4 | 92.66 Million USD | 11.5% |
| 2012 Q3 | 83.11 Million USD | 17.55% |
| 2012 Q2 | 70.7 Million USD | 5.09% |
| 2011 Q3 | 51.38 Million USD | -20.94% |
| 2011 FY | - USD | 3.22% |
| 2011 Q4 | 125.93 Million USD | 145.1% |
| 2011 Q2 | 64.99 Million USD | 9.22% |
| 2011 Q1 | 59.5 Million USD | -30.58% |
| 2010 FY | - USD | 21.44% |
| 2010 Q4 | 85.72 Million USD | 52.71% |
| 2010 Q3 | 56.13 Million USD | 28.8% |
| 2010 Q2 | 43.58 Million USD | 4.86% |
| 2010 Q1 | 41.55 Million USD | -37.99% |
| 2009 Q4 | 67.02 Million USD | 73.54% |
| 2009 Q1 | 39.91 Million USD | -42.32% |
| 2009 Q3 | 38.62 Million USD | -37.92% |
| 2009 FY | - USD | -19.12% |
| 2009 Q2 | 62.21 Million USD | 55.88% |
| 2008 Q3 | 50.91 Million USD | -0.14% |
| 2008 Q4 | 69.19 Million USD | 35.91% |
| 2008 Q1 | 41.06 Million USD | 17.79% |
| 2008 Q2 | 50.98 Million USD | 24.15% |
| 2008 FY | - USD | 38.95% |
| 2007 Q2 | 33.07 Million USD | -4.78% |
| 2007 FY | - USD | -21.15% |
| 2007 Q4 | 34.86 Million USD | -30.27% |
| 2007 Q3 | 50 Million USD | 51.16% |
| 2007 Q1 | 34.73 Million USD | -4.64% |
| 2006 Q3 | 58.88 Million USD | -77.57% |
| 2006 Q1 | 55.81 Million USD | 24.35% |
| 2006 FY | - USD | -3.5% |
| 2006 Q4 | 36.43 Million USD | -38.13% |
| 2006 Q2 | 262.5 Million USD | 370.3% |
| 2005 Q1 | 37.32 Million USD | 3.78% |
| 2005 Q3 | 63.23 Million USD | 14.54% |
| 2005 FY | - USD | 53.57% |
| 2005 Q2 | 55.2 Million USD | 47.89% |
| 2005 Q4 | 44.88 Million USD | -29.01% |
| 2004 Q4 | 35.96 Million USD | -0.52% |
| 2004 Q2 | 30.57 Million USD | 9.37% |
| 2004 Q1 | 27.95 Million USD | -12.19% |
| 2004 FY | - USD | 23.78% |
| 2004 Q3 | 36.15 Million USD | 18.23% |
| 2003 Q1 | 22.79 Million USD | -9.64% |
| 2003 FY | - USD | 44.08% |
| 2003 Q3 | 28.47 Million USD | 20.52% |
| 2003 Q2 | 24.12 Million USD | 4.48% |
| 2003 Q4 | 32.37 Million USD | 13.33% |
| 2002 Q1 | 15.2 Million USD | -30.38% |
| 2002 Q2 | 17.73 Million USD | 25.34% |
| 2002 Q4 | 25.07 Million USD | 48.23% |
| 2002 FY | - USD | 13.35% |
| 2002 Q3 | 20.32 Million USD | -6.17% |
| 2001 Q2 | 16.16 Million USD | 42.51% |
| 2001 Q3 | 16.83 Million USD | 3.07% |
| 2001 Q4 | 20.54 Million USD | 21.76% |
| 2001 FY | - USD | 16.25% |
| 2001 Q1 | 12.2 Million USD | -30.47% |
| 2000 Q3 | 17.35 Million USD | 44.77% |
| 2000 Q4 | 16.54 Million USD | -9.07% |
| 2000 Q1 | 7.8 Million USD | -56.18% |
| 2000 FY | - USD | 18.3% |
| 2000 Q2 | 12.48 Million USD | 59.33% |
| 1999 Q3 | 11.9 Million USD | 11.32% |
| 1999 FY | - USD | 21.76% |
| 1999 Q2 | 10.6 Million USD | 79.66% |
| 1999 Q1 | 5.9 Million USD | -39.18% |
| 1999 Q4 | 17.9 Million USD | 50.85% |
| 1998 Q1 | 5 Million USD | -56.9% |
| 1998 Q3 | 10.2 Million USD | 20.19% |
| 1998 Q4 | 8.7 Million USD | -22.4% |
| 1998 FY | - USD | 26.97% |
| 1998 Q2 | 9.5 Million USD | 108.0% |
| 1997 Q2 | 6.7 Million USD | 54.55% |
| 1997 Q1 | 4.4 Million USD | -48.24% |
| 1997 Q4 | 11.6 Million USD | 50.65% |
| 1997 FY | - USD | 51.24% |
| 1997 Q3 | 7.8 Million USD | 13.24% |
| 1996 Q4 | 8.7 Million USD | 46.55% |
| 1996 Q2 | 4.3 Million USD | 133.33% |
| 1996 Q1 | 1.9 Million USD | -82.69% |
| 1996 FY | - USD | 37.67% |
| 1996 Q3 | 5.8 Million USD | 38.1% |
| 1995 FY | - USD | 3020.0% |
| 1995 Q4 | 5.3 Million USD | 395.24% |
| 1995 Q3 | 3.2 Million USD | 40.0% |
| 1995 Q1 | 1.2 Million USD | 111.67% |
| 1995 Q2 | 1.7 Million USD | 114.29% |
| 1994 Q2 | -300 Thousand USD | 216.67% |
| 1994 Q4 | -600 Thousand USD | -415.79% |
| 1994 Q3 | 1.2 Million USD | 0.0% |
| 1994 Q1 | -1.5 Million USD | -91.3% |
| 1994 FY | - USD | 96.58% |
| 1993 FY | - USD | 52.9% |
| 1993 Q1 | -4.6 Million USD | -219.72% |
| 1993 Q2 | -4.8 Million USD | 40.0% |
| 1993 Q3 | -12.6 Million USD | -147.06% |
| 1993 Q4 | 6.9 Million USD | 154.76% |
| 1992 Q4 | -200 Thousand USD | 139.89% |
| 1992 Q1 | -3.7 Million USD | -3.06% |
| 1992 FY | - USD | 26.19% |
| 1992 Q2 | -3.1 Million USD | -0.99% |
| 1992 Q3 | -12.5 Million USD | -74.51% |
| 1991 Q3 | -7.7 Million USD | -21.78% |
| 1991 Q1 | -6.5 Million USD | 79.25% |
| 1991 Q2 | -8 Million USD | -1.0% |
| 1991 Q4 | -7.1 Million USD | 20.33% |
| 1991 FY | - USD | -38.16% |
| 1990 Q2 | 13.2 Million USD | 28.16% |
| 1990 Q4 | -48.2 Million USD | -519.13% |
| 1990 Q1 | 10.3 Million USD | 119.07% |
| 1990 FY | - USD | -55.9% |
| 1990 Q3 | 11.5 Million USD | -12.88% |
| 1989 Q1 | 14.3 Million USD | 103.34% |
| 1989 FY | - USD | -112.61% |
| 1989 Q3 | 10.7 Million USD | -25.69% |
| 1989 Q4 | -54 Million USD | -604.67% |
| 1989 Q2 | 14.4 Million USD | 0.7% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 2034.607% |
| AngioDynamics, Inc. | -14.29 Million USD | 6276.882% |
| AtriCure, Inc. | -8.1 Million USD | 10986.669% |
| Avinger, Inc. | -16.34 Million USD | 5500.71% |
| Azenta, Inc. | 55.15 Million USD | -1500.696% |
| BioLife Solutions, Inc. | -45.23 Million USD | 2051.457% |
| Daxor Corporation | 329.74 Thousand USD | -267626.087% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 6788.892% |
| Femasys Inc. | -13.16 Million USD | 6803.413% |
| GlucoTrack, Inc. | -7.09 Million USD | 12549.584% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -9199.484% |
| Hologic, Inc. | 1.29 Billion USD | 31.893% |
| ICU Medical, Inc. | 307.69 Million USD | -186.908% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 63.126% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 9491.9% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | -1702.0% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 13526.34% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 13526.34% |
| Masimo Corporation | 236.7 Million USD | -272.962% |
| Microbot Medical Inc. | -10.63 Million USD | 8401.674% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -5497.776% |
| Merit Medical Systems, Inc. | 231.44 Million USD | -281.435% |
| Nephros, Inc. | -1.37 Million USD | 64117.404% |
| NovoCure Limited | -175.86 Million USD | 601.976% |
| NEXGEL, Inc. | -2.73 Million USD | 32436.996% |
| NEXGEL, Inc. | -2.73 Million USD | 32436.996% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 1120.625% |
| OraSure Technologies, Inc. | 76.15 Million USD | -1059.169% |
| Pro-Dex, Inc. | 8.33 Million USD | -10494.024% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 2183.697% |
| Predictive Oncology Inc. | -13.18 Million USD | 6797.005% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 35243.998% |
| QuidelOrtho Corporation | 545.6 Million USD | -61.804% |
| Repligen Corporation | 124.29 Million USD | -610.263% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 305464.635% |
| STAAR Surgical Company | 33.22 Million USD | -2557.355% |
| Sharps Technology, Inc. | -8.98 Million USD | 9930.307% |
| Utah Medical Products, Inc. | 24.8 Million USD | -3458.96% |
| DENTSPLY SIRONA Inc. | 232 Million USD | -280.517% |
| Jin Medical International Ltd. | 3.44 Million USD | -25541.286% |